Quantcast

Latest PDX Stories

2010-06-25 05:41:00

FORT WORTH, Texas, June 25 /PRNewswire/ -- PDX, a leading pharmacy technology provider, and mscripts, a leader in mobile pharmacy technology, today announced an integrated offering that allows PDX Pharmacy System users to communicate with their patients through a variety of mobile communication pathways using the mscripts platform. PDX provides software and services to more than 10,000 retail pharmacies in the United States. mscripts allows pharmacy patients to manage their...

2010-02-25 14:52:00

PORTLAND, Ore., Feb. 25 /PRNewswire/ -- On Sunday, March 21, Portland Global Initiatives, the nonprofit arm of Portland Roasting Coffee Company, will host the second annual World Water Day PDX Walk for Water at the World Trade Center, located at SW First and Salmon Streets in downtown Portland. And on Monday, the same organization will bring the World Water Day PDX Concert Series to the Aladdin Theater, located at 3017 SE Milwaukie Avenue in Portland. Proceeds from both World Water Day...

2009-06-09 06:00:00

The Rx.com Electronic Pharmacy Record (EPR) to Integrate with Microsoft(R) HealthVault(TM) FORT WORTH, Texas, June 9 /PRNewswire/ -- PDX and Rx.com have entered into a strategic agreement with Microsoft to make prescription data, which Rx.com manages for multiple chain and independent pharmacy clients, available to Microsoft HealthVault users by accessing a single site with aggregated prescription data. The agreement enables any pharmacy using the Rx.com Electronic Pharmacy Record (EPR) to...

2009-06-04 08:43:00

Supermarket Gains Latest Pharmacy Management Technology, Will Offer Patients Any-Store Refills FORT WORTH, Texas, June 4 /PRNewswire/ -- Boise, Idaho-based Albertson's, LLC has selected PDX and affiliates Rx.com and NHIN as its turnkey partners of choice for its pharmacy technology solution. Albertson's, LLC is replacing its current system with the all new Enterprise Pharmacy System (EPS), unparalleled in efficiency, safety, and tools for patient care. The chain's pharmacies will also...

2008-11-05 18:00:22

Allos Therapeutics, Inc. (NASDAQ: ALTH) today reported results for the third quarter of 2008. For the three months ended September 30, 2008, the Company reported a net loss of $13.2 million, or ($0.16) per share. This compares to a net loss of $9.3 million, or ($0.14) per share, for the third quarter of 2007. For the nine months ended September 30, 2008, the Company reported a net loss of $37.0 million, or ($0.50) per share, compared to a net loss of $28.1 million, or ($0.43) per share, for...

2008-10-30 18:00:11

Allos Therapeutics, Inc. (Nasdaq: ALTH), a biopharmaceutical company focused on the development and commercialization of small molecule therapeutics for the treatment of cancer, today announced that four abstracts describing results from pralatrexate (PDX) studies have been accepted for presentation at the 50th Annual Meeting of the American Society of Hematology (ASH), to be held December 6 - 9, 2008, in San Francisco, California. The accepted abstracts describe several clinical and...

2008-10-02 21:00:15

By ERIK ROBINSON Representatives of Portland International Airport will have an open house next week in Vancouver to air plans to expand the north runway, manage airport noise and improve water quality. The Port of Portland will host the open house from 5:30 to 7:30 p.m. Wednesday in the community room of C-Tran's Fisher's Landing Transit Center, 3510 S.E. 164th Ave. Items on the agenda: North runway extension: The port plans to lengthen the north runway from 8,000 to 9,825 feet, with...

2008-08-05 18:00:40

Allos Therapeutics, Inc. (NASDAQ: ALTH) today reported results for the second quarter of 2008. For the three months ended June 30, 2008, the Company reported a net loss of $11.8 million, or ($0.16) per share. This compares to a net loss of $10.4 million, or ($0.16) per share, for the second quarter of 2007. For the six months ended June 30, 2008, the Company reported a net loss of $23.8 million, or ($0.34) per share, compared to a net loss of $18.8 million, or ($0.29) per share for the same...

2008-07-22 12:01:09

Allos Therapeutics has started patient enrollment in a Phase II, open-label, single-arm, multi-center study of pralatrexate in patients with advanced or metastatic relapsed transitional cell carcinoma of the urinary bladder. The primary endpoint of the study is objective response rate (complete and partial response). Secondary endpoints include duration of response, clinical benefit rate, progression-free survival (PFS), overall survival and the safety and tolerability of pralatrexate...


Word of the Day
grass-comber
  • A landsman who is making his first voyage at sea; a novice who enters naval service from rural life.
According to the OED, a grass-comber is also 'a sailor's term for one who has been a farm-labourer.'